Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 2/2002

01-04-2003 | Review

Clinical review: Extracorporeal blood purification in severe sepsis

Authors: Ramesh Venkataraman, Sanjay Subramanian, John A Kellum

Published in: Critical Care | Issue 2/2002

Login to get access

Abstract

Sepsis and septic shock are the leading causes of acute renal failure, multiple organ system dysfunction, and death in the intensive care unit. The pathogenesis of sepsis is complex and comprises a mosaic of interconnected pathways. Several attempts to improve patient outcomes by targeting specific components of this network have been unsuccessful. For these reasons, the ideal immunomodulating strategy would be one that restores immunologic stability rather than blindly inhibiting or stimulating one or another component of this complex network. Hence, the recent focus of immunomodulatory therapy in sepsis has shifted to nonspecific methods of influencing the entire inflammatory response without suppressing it. Here, we discuss the various modalities of extracorporeal blood purification, the existing evidence, and future prospects.
Literature
1.
Gotloib L, Barzilay E, Shustak A, Wais Z, Jaichenko J, Lev A: Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung. Resuscitation 1986, 13: 123-132.CrossRef
2.
Stein B, Pfenninger E, Grunert A, Schmitz JE, Hudde M: Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 1990, 16: 494-499.CrossRef
3.
Grootendorst AF, van Bommel EF, van der Hoven B, van Leengoed LA, van Osta AL: High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992, 18: 235-240.CrossRef
4.
Grootendorst AF, van Bommel EF, van Leengoed LA, van Zanten AR, Huipen HJ, Groeneveld AB: Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 1993, 8: 161-169.CrossRef
5.
Lee PA, Matson JR, Pryor RW, Hinshaw LB: Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus -induced septicemia in immature swine. Crit Care Med 1993, 21: 914-924.CrossRef
6.
Bellomo R, Tipping P, Boyce N: Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993, 21: 522-526.CrossRef
7.
Bellomo R, Parkin G, Love J, Boyce N: A prospective comparative study of continuous arteriovenous hemodiafiltration and continuous venovenous hemodiafiltration in critically ill patients. Am J Kidney Dis 1993, 21: 400-404.CrossRef
8.
Jeffrey RF, Khan AA, Prabhu P, Todd N, Goutcher E, Will EJ, Davison AM: A comparison of molecular clearance rates during continuous hemofiltration and hemodialysis with a novel volumetric continuous renal replacement system. Artif Organs 1994, 18: 425-428.CrossRef
9.
Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady JJ, Pinsky MR: Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 1998, 26: 1995-2000. 10.1097/00003246-199812000-00027CrossRef
10.
Brunet S, Leblanc M, Geadah D, Parent D, Courteau S, Cardinal J: Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultra-filtration flow rates. Am J Kidney Dis 1999, 34: 486-492.CrossRef
11.
Ronco R, Bellomo R: Nomenclature for continuous renal replacement therapies. In Critical Care Nephrology (Edited by: Ronco R, Bellomo R). Boston: Kluwer Academic Publishers 1998, 1169-1176.CrossRef
12.
Lebedo I: Predilution hemofiltration: a new technology applied to an old therapy! Int J Artif Organs 1995, 18: 735-742.
13.
Ficheux A, Argiles A, Bosc JY, Mion C: Analysis of the influence of the infusion site on dialyser clearances measured in an in vitro system mimicking haemodialysis and haemodiafiltration. Blood Purif 1999, 17: 10-18. 10.1159/000014360CrossRef
14.
Kellum JA, Mehta RL, Angus DC, Palevsky P, Ronco C: The first international consensus conference on continuous renal replacement therapy. Kidney Int 2002, 62: 1855-1863. 10.1046/j.1523-1755.2002.00613.xCrossRef
15.
16.
Adib-Conquy M, Adrie C, Moine P, Asehnoune K, Fitting C, Pinsky MR, Dhainaut JF, Cavaillon JM: NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am J Respir Crit Care Med 2000, 162: 1877-1883.CrossRef
17.
Adrie C, Pinsky MR: The inflammatory balance in human sepsis. Intensive Care Med 2000, 26: 364-375. 10.1007/s001340051169CrossRef
18.
Abraham E, Matthay MA, Dinarello CA, Vincent JL, Cohen J, Opal SM, Glauser M, Parsons P, Fisher CJ Jr, Repine JE: Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med 2000, 28: 232-235. 10.1097/00003246-200001000-00039CrossRef
19.
Kellum JA, Venkataraman R: Blood purification in sepsis: an idea whose time has come? Crit Care Med 2002, 30: 1387-1388. 10.1097/00003246-200206000-00047CrossRef
20.
von Andrian UH, Mackay CR: T-cell function and migration. Two sides of the same coin. N Engl J Med 2000, 343: 1020-1034. 10.1056/NEJM200010053431407CrossRef
21.
Gomez A, Wang R, Unruh H, Light RB, Bose D, Chau T, Correa E, Mink S: hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 1990, 73: 671-685.CrossRef
22.
Cole L, Bellomo R, Hart G, Journois D, Davenport P, Tipping P, Ronco C: A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002, 30: 100-106.CrossRef
23.
Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000, 356: 26-30. 10.1016/S0140-6736(00)02430-2CrossRef
24.
Silvester W: Mediator removal with CRRT: complement and cytokines. Am J Kidney Dis 1997,30(suppl 4):S38-S43.CrossRef
25.
Rogiers P, Zhang H, Smail N, Pauwels D, Vincent JL: Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 1999, 27: 1848-1855. 10.1097/00003246-199909000-00024CrossRef
26.
Bellomo R, Kellum JA, Gandhi CR, Pinsky MR, Ondulik B: The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 2000, 161: 1429-1436.CrossRef
27.
Heering P, Morgera S, Schmitz FJ, Schmitz G, Willers R, Schultheiss HP, Strauer BE, Grabensee B: Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 1997, 23: 288-296. 10.1007/s001340050330CrossRef
28.
Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P: High-volume haemofiltration in human septic shock. Intensive Care Med 2001, 27: 978-986. 10.1007/s001340100963CrossRef
29.
Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF: Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Med 1999, 25: 814-821. 10.1007/s001340050957CrossRef
30.
Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hanique G, Matson JR: Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000, 28: 3581-3587.CrossRef
31.
Ronco C, Bellomo R: Continuous high flux dialysis: an efficient renal replacement. In Yearbook of Intensive Care and Emergency Medicine (Edited by: Vincent JL). Heidelberg: Springer Verlag 1996, 690-696.CrossRef
32.
Lonnemann G, Bechstein M, Linnenweber S, Burg M, Koch KM: Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure. Kidney Int Suppl 1999, 72: S84-S87.CrossRef
33.
De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999, 10: 846-853.
34.
Kellum JA, Dishart MK: Effect of hemofiltration filter adsorption on circulating IL-6 levels in septic rats. Crit Care 2002, 6: 429-433. 10.1186/cc1528PubMedCentralCrossRef
35.
Winchester JF, Kellum JA, Ronco C, Brady JA, Quartararo PJ, Salsberg JA, Levin NW: Sorbents in acute renal failure and the systemic inflammatory response syndrome. Blood Purif 2003, 21: 79-84. 10.1159/000067860CrossRef
36.
Pond SM: Extracorporeal techniques in the treatment of poisoned patients. Med J Aust 1991, 154: 617-622.
37.
Ronco C, Brendolan A, Winchester JF, Golds E, Clemmer J, Polaschegg HD, Muller TE, Davankov V, Tsyurupa M, Pavlova L, Pavlov M, La Greca G, Levin NW: First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta 2-microglobulin in hemodialysis. Contrib Nephrol 2001, 133: 166-173.CrossRef
38.
Doig GS, Martin CM, Sibbald WJ: Polymyxin-dextran antiendo-toxin pretreatment in an ovine model of normotensive sepsis. Crit Care Med 1997, 25: 1956-1961. 10.1097/00003246-199712000-00009CrossRef
39.
Nakamura T, Suzuki Y, Shimada N, Ebihara I, Shoji H, Koide H: Hemoperfusion with polymyxin B-immobilized fiber attenuates the increased plasma levels of thrombomodulin and von Willebrand factor from patients with septic shock. Blood Purif 1998, 16: 179-186. 10.1159/000014333CrossRef
40.
Nakamura T, Ushiyama C, Suzuki S, Shoji H, Shimada N, Ebihara I, Koide H: Polymyxin b-immobilized fiber reduces increased plasma endothelin-1 concentrations in hemodialysis patients with sepsis. Ren Fail 2000, 22: 225-234. 10.1081/JDI-100100867CrossRef
41.
Aoki H, Kodama M, Tani T, Hanasawa K: Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 1994, 167: 412-417.CrossRef
42.
Ash SR: Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy. Adv Ren Replace Ther 2002, 9: 3-18. 10.1053/jarr.2002.30474CrossRef
43.
Opal SM: Hemofiltration-absorption systems for the treatment of experimental sepsis: is it possible to remove the 'evil humors' responsible for septic shock? Crit Care Med 2000, 28: 1681-1682. 10.1097/00003246-200005000-00088CrossRef
44.
Tetta C, Cavaillon JM, Schulze M, Ronco C, Ghezzi PM, Camussi G, Serra AM, Curti F, Lonnemann G: Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Nephrol Dial Transplant 1998, 13: 1458-1464. 10.1093/ndt/13.6.1458CrossRef
45.
Tetta C, Gianotti L, Cavaillon JM, Wratten ML, Fini M, Braga M, Bisagni P, Giavaresi G, Bolzani R, Giardino R: Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock. Crit Care Med 2000, 28: 1526-1533. 10.1097/00003246-200005000-00045CrossRef
46.
Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A, Dan M, Irone M, La Greca G, Inguaggiato P, Maggiore U, De Nitti C, Wratten ML, Ricci Z, Tetta C: A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002, 30: 1250-1255. 10.1097/00003246-200206000-00015CrossRef
47.
Kellum JA, Somg MC, Venkataraman R, et al.: Improved survival with hemoadsorption in endotoxin induced shock in rats [abstract]. Am J Respir Crit Care Med 2002, 165: A176.CrossRef
48.
Kellum JA: Immunomodulation in sepsis: the role of hemofiltration. Minerva Anestesiol 1999, 65: 410-418.
49.
Berlot G, Lucangelo U, Galimberti G: Plasmapheresis in sepsis. Curr Opin Crit Care 2000, 6: 437-441. 10.1097/00075198-200012000-00012CrossRef
50.
Busund R, Lindsetmo RO, Rasmussen LT, Rokke O, Rekvig OP, Revhaug A: Tumor necrosis factor and interleukin 1 appearance in experimental gram-negative septic shock. The effects of plasma exchange with albumin and plasma infusion. Arch Surg 1991, 126: 591-597.CrossRef
51.
Busund R, Lindsetmo RO, Balteskard L, Rekvig OP, Revhaug A: Repeated plasma therapy induces fatal shock in experimental septicemia. Circ Shock 1993, 40: 268-275.
52.
Natanson C, Hoffman WD, Koev LA, Dolan DP, Banks SM, Bacher J, Danner RL, Klein HG, Parrillo JE: Plasma exchange does not improve survival in a canine model of human septic shock. Transfusion 1993, 33: 243-248. 10.1046/j.1537-2995.1993.33393174451.xCrossRef
53.
Leese T, Holliday M, Heath D, Hall AW, Bell PR: Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitis. Br J Surg 1987, 74: 907-911.CrossRef
54.
Gardlund B, Sjolin J, Nilsson A, Roll M, Wickerts CJ, Wretlind B: Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis 1995, 172: 296-301.CrossRef
55.
Stegmayr B: Apheresis of plasma compounds as a therapeutic principle in severe sepsis and multiorgan dysfunction syndrome. Clin Chem Lab Med 1999, 37: 327-332.CrossRef
56.
Reeves JH, Butt WW, Shann F, Layton JE, Stewart A, Waring PM, Presneill JJ: Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Crit Care Med 1999, 27: 2096-2104. 10.1097/00003246-199910000-00003CrossRef
57.
Stegmayr BG: Plasmapheresis in severe sepsis or septic shock. Blood Purif 1996, 14: 94-101.CrossRef
58.
Mok Q, Butt W: The outcome of children admitted to intensive care with meningococcal septicaemia. Intensive Care Med 1996, 22: 259-263.CrossRef
59.
Berlot G, Gullo A, Fasiolo S, Serra L, Silvestri L, Worz M: Hemo-dynamic effects of plasma exchange in septic patients: preliminary report. Blood Purif 1997, 15: 45-53.CrossRef
60.
Ataman K, Jehmlich M, Kock S, Neumann S, Leischik M, Filipovic Z, Hopf HB: Short-term cardiovascular effects of plasma-pheresis in norepinephrine-refractory septic shock. Intensive Care Med 2002, 28: 1164-1167. 10.1007/s00134-002-1375-6CrossRef
61.
Barzilay E, Kessler D, Berlot G, Gullo A, Geber D, Ben Zeev I: Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients. Crit Care Med 1989, 17: 634-637.CrossRef
62.
Schmidt J, Mann S, Mohr VD, Lampert R, Firla U, Zirngibl H: Plasmapheresis combined with continuous venovenous hemofiltration in surgical patients with sepsis. Intensive Care Med 2000, 26: 532-537. 10.1007/s001340051200CrossRef
63.
Carcillo JA, Kellum JA: Is there a role for plasmapheresis/plasma exchange therapy in septic shock, MODS, and thrombocytopenia-associated multiple organ failure? We still do not know – but perhaps we are closer. Intensive Care Med 2002, 28: 1373-1375. 10.1007/s00134-002-1428-xCrossRef
64.
Busund R, Koukline V, Utrobin U, Nedashkovsky E: Plasma-pheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med 2002, 28: 1434-1439. 10.1007/s00134-002-1410-7CrossRef
65.
Nguyen TC HM, Han YY, Seidberg N, Carcillo JA: Randomized controlled trial of plasma exchange therapy for thrombocytopenia associated multiple organ failure in children [abstract]. Pediatr Res 2001, 49: 42A.
Metadata
Title
Clinical review: Extracorporeal blood purification in severe sepsis
Authors
Ramesh Venkataraman
Sanjay Subramanian
John A Kellum
Publication date
01-04-2003
Publisher
BioMed Central
Published in
Critical Care / Issue 2/2002
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc1889

Other articles of this Issue 2/2002

Critical Care 2/2002 Go to the issue

Commentary

Red man syndrome

Commentary

Recently published papers: changing practices in the modern intensive care unit

Commentary

Why measure cardiac output?

Letter

Positive end-expiratory pressure or no positive end-expiratory pressure: is that the question to be asked?

Letter

Prophylactic positive end-expiratory pressure: are good intentions enough?

Commentary

Low tidal volume, high respiratory rate and auto-PEEP: the importance of the basics